Rise In Drug-Related Deaths Blamed For Increase In UK Mortality Rate

Updated May 20, 2025 | 09:01 AM IST

SummaryDrawing on new research commissioned from the London School of Hygiene & Tropical Medicine, the data suggest improvements in UK death rates slowed down significantly in the 2010s.
Rise In Drug-Related Deaths Blamed For Increase In UK Mortality Rate

Credit: Canva

The newly-released figures show a troubling trend in death rates in the UK when compared with 21 other high-income countries, as well as finding deep inequalities in health between different parts of the UK.

Drawing on new research commissioned from the London School of Hygiene & Tropical Medicine, the data suggest improvements in UK death rates slowed down significantly in the 2010s, more so than in most of the 21 other high-income countries studied.

By 2023, female mortality rates in the UK were 14% higher than the median of peer countries, with male mortality rates 9% higher. The research reveals significant inequalities across the UK.

Scotland, Wales and Northern Ireland all have higher mortality rates than England, with Scotland performing particularly poorly. In 2021, only the US had a worse mortality rate than Scotland among the countries studied, while mortality rates were 20% higher in the North East and North West of England than in the South West.

Read more: Russia and Ukraine to 'immediately' start ceasefire talks as Zelenskyy pitches ‘high-level’ meeting of world leaders

The relative worsening of death rates among the working age population is particularly stark. In 2023, female mortality rates for people aged 25-49 were 46% higher than the median of the other countries studied, and male rates were 31% higher.

Only Canada and the US experienced a similar worsening of death rates among this age group during the 2010s.

Poorer working age health in the UK is leading to lower labour force participation and acting as a drag on growth. Among the top three causes of death for people aged 25–49, death rates for cancers and circulatory diseases improved between 2001 and 2019.

In contrast, death rates from external causes (deaths due to injuries, poisonings and violence) worsened, accounting for 70%-80% of the difference in UK death rates at this age compared to the median of the countries studied over this period.

The research found that this is being fuelled by a shocking rise in drug-related deaths, with the rate of drug-related deaths in the UK more than three times higher in 2019 than the average of peer countries. It also found stark geographic inequalities in drug-related deaths.

In 2019, the drug-related mortality rate among 25–49-year-olds in Scotland was around 4 times higher than in England. Within England, the drug-related mortality rate in the North East was 3.5 times higher for males and almost 4 times higher for females than in London.

With the UK's health comparing increasingly poorly with other high-income countries, the Health Foundation is calling for a new strategy to tackle health inequalities, alongside long-term action to rebuild the nation's health and promote economic recovery in areas of long run industrial decline.

Dame Jennifer Dixon, Chief Executive of the Health Foundation, said: “This report is a health check we can’t afford to ignore – and the diagnosis is grim.

"The UK is becoming the sick person of the wealthy world, especially for people of working age. While other nations moved forward, we stalled – and in some areas, slipped badly behind."

The soaring drug-related deaths in Scotland and the North East are not just tragic – they are symptoms of long-standing neglect, economic stagnation and policy failure.

It’s clear that sticking plasters won’t cut it: we need a bold, long-term health strategy that tackles prevention, inequality, and underinvestment in public health head-on. And in particular far more urgent and targeted action on drugs.

“Improvements are possible and urgently needed Improving the nation’s health is not a luxury – it’s a necessity for economic growth and social stability.”

End of Article

First Locally Acquired Clade 1 Mpox Case Detected California, Symptoms You Should Look Out For

Updated Oct 17, 2025 | 09:00 PM IST

SummaryA recent news report from the health department of Long Beach revealed that the first locally acquired Mpox case has been reported in the area, and people are being warned. The disease is contagious and the strain that was detected was clade 1, which is much more severe than clade 2.
First Locally Acquired Clade 1 Mpox Case Detected California, Symptoms You Should Look Out For

(Credit-Canva)

The Long Beach Department of Health and Human Services has confirmed its first case of locally acquired Clade-1 Monkeypox strain. In a recent press release, the authorities informed the citizens that the person who was diagnosed had no recent travel history, which means the virus was contracted locally.

While the risk for the public remains low, the health department warns people to stay safe. Since it is a contagious disease, the health investigation is still ongoing, as the public officers comb through the person’s history. However, currently there are no other cases of the clade 1 mpox. Mayor Rex Richardson said, “While the overall risk of mpox clade I exposure to the public remains low, we are taking this very seriously and ensuring our community and health care partners remain vigilant so we can prevent any more cases.”

What Is Mpox?

According to the World Health Organization, Mpox (previously called monkeypox) is a sickness caused by a virus. Think of it as being like different types of flu—there are a few versions of the mpox virus, called clades.

The global outbreak that happened in 2022–2023 was caused by one of these versions, specifically Clade IIb. The virus spreads through close contact with an infected person's sores or body fluids, with contaminated items like bedding, or with infected animals. The virus can also be passed from a pregnant person to their baby.

Most mpox treatment involves supportive care—doctors help manage symptoms like pain and fever while the body recovers. This includes keeping the patient well-nourished and hydrated, caring for the rash, and addressing any secondary infections. Fortunately, vaccines are available for mpox.

How is Clade 1 Different From Clade 2?

This new case involves Clade 1 mpox, which is historically associated with more severe illness and is typically found in Central and East Africa.

In contrast, the large 2022-2023 outbreak in the U.S. and globally was caused by Clade 2, which usually results in milder illness. Mpox, regardless of the clade, spreads through direct contact with sores, body fluids, intimate contact, or contaminated items. Symptoms can include a rash or sores, fever, chills, sore throat, swollen lymph nodes, and body aches.

What Are The Health Risks of Mpox?

Long Beach health officials are currently investigating the patient's source of exposure and conducting contact tracing, though no other cases have been identified so far.

Long Beach Mayor Rex Richardson emphasized that while the overall risk to the public remains low, the city is taking the situation seriously. He stressed the importance of continued surveillance, early response, and vaccination.

A Long Beach public health physician, Dr. Cliff Okada, advised: "Anyone with an unexplained rash or lesions should seek care promptly. Speak openly with intimate partners and your healthcare provider. Early action protects you and others."

Who Is At Risk For Mpox Clade 1?

The Centers for Disease Control and Prevention (CDC) continues to recommend the Jynneos vaccine for people at high risk of exposure. This includes gay, bisexual, and other men who are intimately involved with other men, transgender and non-binary people, those with weakened immune systems (such as people with HIV), individuals exposed to an infected person, those with occupational exposure, and people traveling to areas with ongoing outbreaks.

Most mpox patients recover on their own within 2 to 4 weeks. A booster shot is not currently recommended for those who have completed the two-dose vaccine series.

End of Article

Liam Payne’s Girlfriend Kate Cassidy Opens Up About Her Depression Following Singer’s Death

Updated Oct 17, 2025 | 07:51 AM IST

SummaryA year after Liam Payne’s tragic death, his girlfriend Kate Cassidy reflected on her grief and depression. The 26-year-old shared how she struggled to function for weeks before deciding to rebuild her life by waking early, exercising, and eating healthy. Cassidy said staying active and busy helped her slowly heal and embrace life again.
Liam Payne’s Girlfriend Kate Cassidy Opens Up About Her Depression Following Singer’s Death

Credits: Canva

Liam Payne's death marks a whole year, and his girlfriend Kate Cassidy reflected on his death anniversary. She also opened up about her depression after his death. Cassidy lost her boyfriend, former One Direction member in 2024, and as she said, her world collapsed.

The 26-year-old social media star has now opened up about her painful journey through grief, depression, and eventually healing.

In an interview to Page Six, she said, "I was always just kind of doing nothing and just dealing with that grief and pain. I was admittedly mired in depression and just not wanting to really live my life.”

For weeks, Cassidy found herself unable to function, trapped between disbelief and heartbreak. But around two months later, something shifted.

“I finally realized, ‘OK, like I need to live my life. I need to get up, get out of bed,’” she recalled.

The Way To Healing

However, she was determined to pull herself out of darkness and so she began to rebuild her days, one small habit at a time. She started to set her alarm earlier each morning, forcing herself to wake up and move. "I began working out, eating clean," she said. "I like to always be up early, have a workout class planned, go for a nice walk, eat cleaner. For me, being active always keep my mind so much cleaner and healthier," she explained.

Gradually, she also learned to navigate her life without Payne, and kept herself busy. She said that she tried to be as busy as she can to help her headspace.

Also Read: Liam Payne Investigation: How Pink Cocaine Affects You?

Acknowledging The Hard Truth

Payne's death was a devastating news for her as well as for her fans. The 31-year-old singer died in October 2024, after falling from a third-storey balcony at the CasaSur Palermo Hotel in Buenos Aries, Argentina.

An autopsy report later revealed that Payne had drugs in his system and the authorities determined that he fell to his death while trying to escape the hotel room after he was locked in.

Cassidy had joined Payne on the trip, but returned home two days before his death. Following his death, she revealed that they had talked about spending their lives together. "We had so many plans. He lit up my room. He was just so sweet, so funny. I've never met anybody like him and I'm sure I probably won't ever meet anybody like him in my life."

Almost a year later, Cassidy is filled with both sorrow and gratitude. "In a way, I am glad that he is going to be that one person. He was the best person I ever met."

Cassidy said that through grief she is learning to embrace life again.

What Depression Feels Like After You Lose Someone

Cassidy opened up that right after losing Payne, she felt like she could not live anymore. While grief and loss is a natural emotional response to the loss of someone close, often, one slips through depression, if they are not able to cope with the loss.

Depression is a mood disorder and it causes a persistent feeling of sadness, and further affects your emotional and physical well-being.

NHS UK notes that people who deal with grief and loss feel shock and first and numb after and then they go into the phase of overwhelming sadness, tiredness, exhaustion, and sometimes anger.

However, there are things one can do, notes NHS UK, which includes talking to a friend, a mental health expert, go for peer support, and try to bring in simple lifestyle changes to help you feel more in control and able to cope.

End of Article

Johnson & Johnson Faces Major UK Lawsuit Over Alleged Cancer-Causing Contents in Baby Powder

Updated Oct 17, 2025 | 06:43 AM IST

SummaryA UK lawsuit involving 3,000 claimants accuses Johnson & Johnson of knowingly selling asbestos-contaminated baby powder since the 1960s. Internal memos suggest the company concealed cancer risks while marketing the product as safe. J&J denies wrongdoing, claiming compliance with safety standards. The case could become Britain’s largest product liability suit.
Johnson & Johnson Faces Major UK Lawsuit Over Alleged Cancer-Causing Contents in Baby Powder

Credits: J&J Website

Johnson Baby Talcum Powder: A major lawsuit has been filed in the UK against the popular pharmaceutical giant Johnson & Johnson (J&J). The company is accused of knowingly selling baby powder that contains asbestos, a substance linked to deadly cancers.

The legal claim is being led by KP law, and involved around 3,000 people. The company is alleged to be aware for decades that its talc-based baby powder contained cancer-causing fibers.

Decades of Warnings Ignored

BBC reports that as per the court papers, J&K knew about this in as early as in the 1960s. The company was aware that the talc contained fibrous forms of tremolite and actinolite, both of which are classified as asbestos when in fibrous form. However, the company failed to warn its consumers and promoted the product as 'safe' and 'pure'.

The documents accessed by the BBC from 1973 notes that the company acknowledged, "our baby powder contains talc fragments classifiable as fibre. Occasionally sub-trace quantities of tremolite or actinolite are identifiable".

However, no public memo was issued, instead the company's executives discussed it to keep the findings confidential. One memo also reported, "We may wish to keep the whole thing confidential rather than allow it to be published in patent form and thus let the whole world know.”

However, J&J currently is denying all such claims and said that the baby powder "was compliant with all regulatory standards, did not contain asbestos, and does not cause cancer.” The company’s UK sales of talc-based powder ended in 2023.

Who Is Safe, Who Is Not?

The lawsuit against J&J alleges that instead of warning the customers, the company continued to maintain the product's wholesome image of 'purity'. During the 1970s and 80s advertisements, the powder was shown as gentle and safe for newborns. By 1990s and early 2000s, the company shifted its marketing focus toward African American women.

In an email from 2008, one employee wrote: "The reality that talc is unsafe for use on/around babies is disturbing. I don’t think we can continue to call it baby powder and keep it in the baby aisle.”

Kenvue, J&J’s consumer health spinoff, said the email was taken out of context, claiming it referred to the known risk of asphyxiation, not cancer, reported the BBC.

Pressure On Regulators

Several documents cited in the legal claim that the company also worked to influence the US regulators. From the early 1970s, the company pushed the Food and Drug Administration (FDA) to accept testing standards that were less sensitive. This meant that smaller amounts of asbestos could go undetected.

The company proposed tolerance levels of asbestos up to 1%, in talc, and said that sensitive tests were unnecessary. This allowed the company to continue with their claim that the product is 'asbestos-free'. All these claims have been dismissed by Kenvue, saying that the document in reference is a 'hypothetical calculation' requested by the FDA.

What Is The Human Cost?

Many of the claimants have either developed or lost loved ones to ovarian cancer, mesothelioma, or other asbestos-related illnesses.

One such claimant, Siobhan Ryan, a 63-year-old from Somerset, recalls using J&J baby powder on her children, just as her mother had used it on her. “It smelt nice and was soft and lovely. I thought I was doing my best for them,” she told the BBC.

Years later, she was diagnosed with stage 4 ovarian cancer. After rounds of chemotherapy, major surgery, and a near-fatal case of sepsis, Siobhan is still undergoing treatment. “They knew it was contaminated and still they sold it to new mums and their babies,” she said.

The consequences are beyond the UK. The same is on going in the United States, where multiple lawsuits against the company have already been filed. Earlier this month, a Connecticut court ordered J&J and its successors to pay $25 million to a man diagnosed with terminal peritoneal mesothelioma after lifelong use of the baby powder. The jury found J&J negligent, noting that safer alternatives like cornstarch were available but ignored.

During that trial, a former J&J toxicology director admitted he had made public safety assurances without reviewing any test data and failed to report results that showed asbestos in the product.

What Is The Company's Take?

While the company said that it "sympathizes deeply with people living with cancer", it maintained its stance that the powder is safe to use and that it "did not contain asbestos and does not cause cancer."

However, lawyers in the UK say damages could reach hundreds of millions of pounds, making this potentially the largest product liability case in British history.

End of Article